Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 12, 1997, Pages 815-821

  Takikawa, Hajime ^a   Yokote, Michiko ^a   Sano, Naoyo ^a   Kuyama, Yasushi ^a   Yamanaka, Masami ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Active transport; Bile acid; Intestinal absorption; Passive diffusion; Tauroursodeoxycholate; Ursodeoxycholate

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID; TAUROCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ILEUM; INTESTINE ABSORPTION; INTESTINE PERFUSION; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031425757     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00377.x     Document Type: Article

References (34)

1. Lack L, Weiner IM. In vitro absorption of bile salts by small intestine of rats and guinea pigs. Am. J. Physiol. 1961; 200: 313-17.
2. Playoust MR, Isselbacher KJ. Studies on the transport and metabolism of conjugated bile salts by intestinal mucosa. J. Clin. Invest. 1964; 43: 467-76.
3. Lack L, Weiner IM. Intestinal bile salt transport: Structure-activity relationship and other properties. Am. J. Physiol. 1966; 210: 1142-52.
4. Shiff ER, Small NC, Dietschy JM. Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J. Clin. Invest. 1972; 51: 1351-62.
5. Gallagher K, Mauskopf J, Walker JT, Lack L. Ionic requirements for the active ileal bile salt transport system. J. Lipid Res. 1976; 17: 572-7.
6. Wilson FA, Dietschy JM. Characterization of bile acid absorption across the unstirred water layer and brush border of the rat jejunum. J. Clin. Invest. 1972; 51: 3015-25.
7. Amelsberg A, Schteingart CD, Ton-Nu H-T, Hofmann AF. Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig. Gastroenterology 1996; 110: 1098-106.
8. Krag E, Phillips SF. Active and passive bile acid absorption in man. J. Clin. Invest. 1974; 53: 1686-94.
9. Gong YZ, Zwarych Jr PP, Lin MC, Wilson FA. Effect of antiserum to a 99 kDa polypeptide on the uptake of taurocholic acid by rat ileal brush border membrane vesicles. Biochem. Biophys. Res. Commun. 1991; 179: 204-9.
10. Shneider BL, Dawson PA, Christie D-M, Wong MH, Suchy FJ. Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J. Clin. Invest. 1995; 95: 745-54.
11. Makino I, Shinozaki K, Yoshino K, Nakagawa S. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn. J. Gastroenterol. 1975; 72: 690-702.
12. Tokyo Cooperative Gallstone Study Group. Efficacy and indication of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double blind trial. Gastroenterology 1980; 78: 542-8.
13. Poupon R, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i: 834-6.
14. Leuschner U, Fisher H, Kurtz W et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind trial. Gastroenterology 1989; 7: 1268-74.
15. Leuschner U, Leuschner M, Sieratzki J, Kurtz W, Hübner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow up. A pilot study. Dig. Dis. Sci. 1985; 30: 642-9.
16. Takikawa H, Yamanaka M, Miyake K et al. Ursodeoxycholic acid therapy for chronic type C hepatitis: A multicenter, dose-finding trial. Curr. Ther. Res. 1994; 55: 16-21.
17. Kitani K, Kanai S. Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci. 1982; 31: 515-23.
18. Utili R, Tripodi MF, Adinolfi LE, Gaeta GB, Abernathy CO, Zimmerman HJ. Estradiol-17β-D-glucuronide (E-17G) cholestasis in perfused rat liver: Fate of E-17G and choleretic responses to bile salts. Hepatology 1990; 11: 735-42.
19. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak W, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology 1991; 100: 203-11.
20. Sano N, Takikawa H, Yamanaka M. Estradiol-17β-glucuronide-induced cholestasis: Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. J. Hepatol. 1993; 17: 241-6.
21. Takikawa H, Minagawa K, Sano N, Yamanaka M. Lithocholate-3-O-glucuronide-induced cholestasis: A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates. Dig. Dis. Sci. 1993; 38: 1543-8.
22. Portincasa P, Palmieri V, Dronzo F et al. Effect of tauroursodeoxycholic acid on serum liver enzymes and dyspeptic symptoms in patients with chronic active hepatitis. Curr. Ther. Res. 1993; 53: 521-32.
23. Ota M, Minami Y, Hoshita T. Intestinal absorption of ursodeoxycholic, glycoursodeoxycholic and tauroursodeoxycholic acids in rats. J. Pharmacobio. Dyn. 1985; 8: 114-18.
24. Aldini R, Roda A, Lenzi PL et al. Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring. Eur. J. Clin. Invest. 1992; 22: 744-50.
25. Aldini R, Montagnani M, Roda A, Hrelia S, Biagi PL, Roda E. Intestinal absorption of bile acids in the rabbit: Different transport rates in jejunum and ileum. Gastroenterology 1996; 110: 459-98.
26. Takikawa H, Narita T, Sano N, Yamanaka M. Glucuronidation of bile acids by their high-dose infusion into rats. Hepatology 1991; 13: 1222-8.
27. Takikawa H, Ookhtens M, Stolz A, Kaplowitz N. Cyclical oxidation-reduction of the C position on bile acids catalyzed by 3α-hydroxysteroid dehydrogenase. II. Studies in the prograde and retrograde single-pass, perfused rat liver and inhibition by indomethacin. J. Clin. Invest. 1987; 80: 861-6.
28. Marcus SN, Schteingart CD, Marquez ML et al. Active absorption of conjugated bile acids in vivo. Gastroenterology 1991; 100: 212-21.
29. Takikawa H, Yokote M, Sano N, Nakaki M, Yamanaka M. Intestinal absorption of lithocholate and its sulfate and glucuronide in rats. J. Gastroenterol. Hepatol. 1995; 10: 383-6.
30. Takikawa H, Sano N, Ohki H, Yamanaka M. Comparison of biliary excretion and metabolism of lithocholic acid and its sulfate and glucuronide conjugates in rats. Biochim. Biophys. Acta 1989; 1004: 147-50.
31. Small DM. The physical chemistry of cholanic acids. In: Nair PP, Kritchevsky D, eds. The bile acids Vol. 1. New York: Plenum, 1971; 249-56.
32. Mekhjain HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: Perfusion studies in man. Dig. Dis. Sci. 1979; 24: 545-50.
33. Igimi H, Carey MC. PH-solubility relations of chenodeoxycholic and ursodeoxycholic acids: Physical-chemical basis for dissimilar solution and membrane phenomena. J. Lipid Res. 1980; 21: 72-80.
34. Roda A, Minutello A, Angellotti MA, Fini A. Bile acid structure - activity relationship: evaluation of bile acid hydrophobicity using 1-octanol/water partition coefficient and reverse phase HPLC. J. Lipid Res. 1990; 31: 1433-43.